---
figid: PMC7463546__cancers-12-02203-g001
figlink: pmc/articles/PMC7463546/figure/cancers-12-02203-f001/
number: F1
caption: Schematic diagram of the NF-κB signaling pathway and anti-multiple myeloma
  (MM) drug targets. First-line anti-MM drugs (highlighted in orange) passively target
  the canonical and/or non-canonical pathways to shut down NF-κB signaling. For example,
  bortezomib inhibits the 26S proteasome to hinder the processing of p105 and p100
  proteins, to prevent gene transcription activation in canonical and non-canonical
  NF-κB signaling pathways, respectively; dexamethasone induces IκB protein synthesis
  to inhibit p105 processing; lenalidomide reduces RelA binding to open chromatin;
  cyclophosphamide is a DNA alkylating agent that disrupts DNA replication and genome
  stability. Ligands, adaptor proteins and transcriptional complexes involved in canonical
  NF-κB signaling are depicted in dark blue, whereas those involved in non-canonical
  NF-κB signaling are depicted in light blue; kinases are depicted in green; inhibitors
  are depicted in red. P and Ub indicate the post-translational modifications of phosphorylation
  and ubiquitination, respectively. Arrows with triangle heads indicate activation,
  whereas arrows with rhomboid heads indicate inactivation/inhibition; direct interactions
  are indicated by solid lines, whereas indirect interactions are indicated by dash
  lines.
pmcid: PMC7463546
papertitle: Targeting NF-κB Signaling for Multiple Myeloma.
reftext: Ada Hang-Heng Wong, et al. Cancers (Basel). 2020 Aug;12(8):2203.
pmc_ranked_result_index: '3842'
pathway_score: 0.9361643
filename: cancers-12-02203-g001.jpg
figtitle: NFKB signaling pathway and anti-multiple myeloma (MM) drug targets
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7463546__cancers-12-02203-g001.html
  '@type': Dataset
  description: Schematic diagram of the NF-κB signaling pathway and anti-multiple
    myeloma (MM) drug targets. First-line anti-MM drugs (highlighted in orange) passively
    target the canonical and/or non-canonical pathways to shut down NF-κB signaling.
    For example, bortezomib inhibits the 26S proteasome to hinder the processing of
    p105 and p100 proteins, to prevent gene transcription activation in canonical
    and non-canonical NF-κB signaling pathways, respectively; dexamethasone induces
    IκB protein synthesis to inhibit p105 processing; lenalidomide reduces RelA binding
    to open chromatin; cyclophosphamide is a DNA alkylating agent that disrupts DNA
    replication and genome stability. Ligands, adaptor proteins and transcriptional
    complexes involved in canonical NF-κB signaling are depicted in dark blue, whereas
    those involved in non-canonical NF-κB signaling are depicted in light blue; kinases
    are depicted in green; inhibitors are depicted in red. P and Ub indicate the post-translational
    modifications of phosphorylation and ubiquitination, respectively. Arrows with
    triangle heads indicate activation, whereas arrows with rhomboid heads indicate
    inactivation/inhibition; direct interactions are indicated by solid lines, whereas
    indirect interactions are indicated by dash lines.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1A
  - IL1B
  - TNFSF11
  - CD40LG
  - TNF
  - LTBR
  - TNFRSF11A
  - EGF
  - IL1R1
  - TNFSF13B
  - CD40
  - EGFR
  - TRAF2
  - TNFRSF13C
  - MAP3K7CL
  - NR2C2
  - AK1
  - TRAF6
  - TRAF3
  - TRAF5
  - CHUK
  - NLK
  - IKBKB
  - IKBKG
  - RELA
  - RELB
  - Dexamethasone
  - Prednisone
  - Bortezomib
  - Carfilzomib
  - Ixazomib
  - Aspirin
  - Lenalidomide
  - Polmalidomide
  - Thalidomide
  - Cyclophosphamide
  - Doxorubicin
  - Melphalan
  - Bendamustine
  - Cisplatin
  - Etoposide
  - CIAPS
genes:
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: RANKL
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
- word: CD4OL
  symbol: CD40L
  source: hgnc_alias_symbol
  hgnc_symbol: CD40LG
  entrez: '959'
- word: TNFa
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: LTBR
  symbol: LTBR
  source: hgnc_symbol
  hgnc_symbol: LTBR
  entrez: '4055'
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: BAFF
  symbol: BAFF
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF13B
  entrez: '10673'
- word: CD40
  symbol: CD40
  source: hgnc_symbol
  hgnc_symbol: CD40
  entrez: '958'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: BAFFR
  symbol: BAFFR
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF13C
  entrez: '115650'
- word: ТАК1
  symbol: TAKL
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K7CL
  entrez: '56911'
- word: ТАК1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: ТАК1
  symbol: AK1
  source: hgnc_symbol
  hgnc_symbol: AK1
  entrez: '203'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF2/5/6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TRAF2/5/6
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF2/5/6
  symbol: TRAF5
  source: hgnc_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: IKKA
  symbol: IKKA
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: NIK
  symbol: NLK
  source: hgnc_symbol
  hgnc_symbol: NLK
  entrez: '51701'
- word: IKKB
  symbol: IKKB
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKKA
  symbol: IKKA
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
chemicals:
- word: Dexamethasone
  source: MESH
  identifier: D003907
- word: Prednisone
  source: MESH
  identifier: D011241
- word: Bortezomib
  source: MESH
  identifier: C400082
- word: Carfilzomib
  source: MESH
  identifier: C524865
- word: Ixazomib
  source: MESH
  identifier: C548400
- word: Aspirin
  source: MESH
  identifier: D001241
- word: Lenalidomide
  source: MESH
  identifier: C467567
- word: Polmalidomide
  source: ''
  identifier: ''
- word: Thalidomide
  source: MESH
  identifier: D013792
- word: Cyclophosphamide
  source: MESH
  identifier: D003520
- word: Doxorubicin
  source: MESH
  identifier: D004317
- word: Melphalan
  source: MESH
  identifier: D008558
- word: Bendamustine
  source: MESH
  identifier: C001758
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Etoposide
  source: MESH
  identifier: D005047
diseases:
- word: CIAPS
  source: ''
  identifier: ''
figid_alias: PMC7463546__F1
redirect_from: /figures/PMC7463546__F1
figtype: Figure
---
